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Fanconi anemia (FA) is a rare autosomal recessive disease manifested by bone-marrow failure and an elevated
incidence of cancer. Cells taken from patients exhibit spontaneous chromosomal breaks and rearrangements. These
breaks and rearrangements are greatly elevated by treatment of FA cells with the use of DNA cross-linking agents.
The FA complementation group D gene (FANCD) has previously been localized to chromosome 3p22-26, by use
of microcell-mediated chromosome transfer. Here we describe the use of noncomplemented microcell hybrids to
identify small overlapping deletions that narrow the FANCD critical region. A 1.2-Mb bacterial-artificial-chro-
mosome (BAC)/P1 contig was constructed, bounded by the marker D3S3691 distally and by the gene ATP2B2
proximally. The contig contains at least 36 genes, including the oxytocin receptor (OXTR), hOGG1, the von Hippel-
Lindau tumor-suppressor gene (VHL), and IRAK-2. Both hOGG1 and IRAK-2 were excluded as candidates for
FANCD. BACs were then used as probes for FISH analyses, to map the extent of the deletions in four of the
noncomplemented microcell hybrid cell lines. A narrow region of common overlapping deletions limits the FANCD
critical region to ∼200 kb. The three candidate genes in this region are TIGR-A004X28, SGC34603, and AA609512.
Introduction
Fanconi anemia (FA) is a rare autosomal recessive dis-
ease characterized by pancytopenia and a specific sen-
sitivity, at the cellular level, to DNA cross-linking
agents. FA cells generally show normal resistance to
other DNA-damaging agents, such as ultraviolet light,
ionizing radiation, or monofunctional DNA-alkylat-
ing agents (Weksberg et al. 1979; Klocker et al. 1985;
Moustacchi and Diatloff-Zito 1985); however, the re-
sults of a recent analysis of FA lymphoblasts from
various complementation groups have suggested that
some FA cells may be sensitive to bleomycin (Carreau
et al. 1999). The primary defect might involve a spe-
cific pathway associated with the repair of DNA cross-
links, although this hypothesis remains to be proved.
The genes for FA complementation groups A, C, and
G have been cloned (Strathdee et al. 1992; Fanconi
Anaemia/Breast Cancer Consortium 1996; Lo Ten Foe
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et al. 1996; de Winter et al. 1998), and the FA com-
plementation group E gene (FANCE) has been
mapped (Waisfisz et al. 1999). There are at least eight
FA complementation groups (Joenje et al. 1997). The
functions of the genes remain elusive.
The FANCD gene has previously been mapped to
chromosome 3p22-26 (Whitney et al. 1995). The
PD20 cell line that was used to map this gene has
been assigned to complementation group D (Jakobs
et al. 1996). To map the gene that is defective in the
PD20 cells, we used microcell-mediated chromosome
transfer (MMCT) followed by a cytogenetic assay for
functional complementation. MMCT was used to
move individual neomarked human chromosomes
into the PD20 immortalized fibroblast cell line. Dur-
ing the fusion process, a donor chromosome can be-
come partially deleted or rearranged. In the initial set
of 25 microcell hybrids, one hybrid (PD20-3-8) ap-
peared to contain an intact neomarked p arm of chro-
mosome 3, but it continued to show high levels of
chromosomal breaks and radials when exposed to
mitomycin C (MMC) and diepoxybutane (DEB). We
hypothesized that this was the result of the presence
of a small deletion containing the FA complementa-
tion group D gene (FANCD; MIM 227646). This hy-
pothesis was the basis for a strategy to narrow the
FANCD region of interest: a large number of micro-
cell hybrids were generated to screen for additional
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noncomplemented clones. If these microcell hybrids
carried independent, overlapping deletions, then the
region of common overlap would delimit the FANCD
critical region.
In the course of mapping the small deletions in these
noncomplemented microcell hybrids, a bacterial-artifi-
cial-chromosome (BAC)/P1 contig was assembled. The
contig was useful not only for the fine mapping of mark-
ers and expressed-sequence tags (ESTs) in the critical
region but, also, for FISH analyses with the use of BACs
as probes. Use of BAC probes for FISH analysis of the
noncomplemented microcell hybrids determined the ex-
tent of deletions on the respective neomarked donor
chromosomes. Overlapping deletions in the five non-
complemented microcell hybrids restricted the FANCD
critical region to ∼200 kb.
Material and Methods
Cell Lines
PD20 is an immortalized FANCD fibroblast cell line
generated by the Oregon Health Sciences University Fan-
coni Anemia Cell Repository (Jakobs et al. 1996). The
mouse cell line A9 as well as the human/mouse hybrid
donor cell line GM11713 (A913) were obtained from
the National Institute of General Medical Sciences Hu-
man Genetics Mutant Cell Repository. Murine cell lines,
including the human/mouse hybrids, were cultured in
Dulbecco modified essential medium (DMEM) with
15% bovine calf serum (Hyclone). Human fibroblasts
and microcell hybrids were cultured in a-MEM (minimal
essential medium) and 20% FCS (Summit). To all media,
we added 2 mM glutamine and 500 mg penicillin-strep-
tomycin/ml.
MMCT
MMCT was performed as described elsewhere
(Fournier et al. 1981). In brief, donor cells were split
onto 150-mm dishes at ∼40% confluence and were
allowed to recover for 24 h. Colcemid (0.06 mg/ml for
mouse cell lines and 1.0 mg/ml for human cell lines;
Sigma) was added, and the cells were incubated for
24–48 h. Micronucleated cells were then trypsinized
and were allowed to settle down on “bullets” coated
with cross-linked concanavalin A (Sigma). The bullets
were then placed into 50-ml centrifuge tubes contain-
ing DMEM and 10 mg cytochalasin B (Sigma)/ml and
were centrifuged at 14,000 rpm (g force 27,000; Beck-
man JA-17 rotor) for 30 min at 377C. The resulting
pellets were resuspended in DMEM without serum
and were filtered through a 5-mm syringe filter (Mil-
lex-SV filter unit; Millipore). The microcells were then
mixed with phytohemagglutinin solution (final con-
centration in media 100 mg phytohemagglutinin P
[Difco]/ml) and were added to a monolayer of recip-
ient cells. After 15 min, the cells and microcells were
fused with 50% polyethylene glycol for 1 min (Mercer
and Schlegel 1979), were washed with a serum-free
medium, and were allowed to recover overnight with-
out selection. The next day, the cells were split 1:10
into selective media containing 400 mg G418
(GibcoBRL)/ml. After the selection was complete,
clones were picked, expanded, and analyzed in-
dependently.
Chromosome-Breakage Analysis
Chromosome-breakage analysis was performed by
the Cytogenetics Core Lab at Oregon Health Sciences
University, Portland, Oregon. For the analysis (Cohen
et al. 1982), cells were plated into T25 flasks and were
allowed to recover overnight. Fibroblast cell lines
were then treated with either 40 ng MMC/ml or 200
ng DEB/ml for 2 d. After treatment, the cells were
exposed to colcemid for 3 h and were harvested with
the use of 0.075 M KCl and 3:1 methanol:acetic acid.
Slides were stained with Wright stain, and chromo-
somes were scored for breaks and radials per cell.
FISH Analysis
Localization of BACs to chromosome 3p25, by means
of metaphase FISH, was done by nick translation of BAC
DNA with the use of digoxygenin-11-dUTP (Boehringer
Mannheim) or biotin-11-dUTP (Enzo Diagnostics), and
detection was done with the use of anti-digoxygenin-
rhodamine or avidin-fluorescein isothiocyanate (FITC)
(Oncor). To order BACs within the contig by means of
interphase FISH, we used a rhodamine-tagged probe
(Oncor) to chromosome 3p subtelomeric sequences, in
addition to pairs of labeled BAC probes, one of which
was detected with the use of FITC and the other of which
was detected with the use of rhodamine. In a second
analysis, we labeled a chromosome 3p subtelomeric
probe (a gift from D. H. Ledbetter) with biotin. By com-
parison of the linear order of colored probes (e.g., red-
green-red or green-green-red), the order of a given pair
of BACs, with respect to the telomere, was established.
A minimum of 50 nuclei were examined for each FISH
analysis.
To identify the neomycin-marked chromosome 3 in
the microcell hybrids, the eukaryotic expression vector
pXT1 (Stratagene), which contains the neomycin-resis-
tance gene, was used as a FISH probe. After Qiagen
purification, the vector was nick-translated with digox-
ygenin-11-dUTP (Boehringer Mannheim) and was de-
tected with anti-digoxigenin FITC (Oncor). The cells
were counterstained with propidium iodide, and a min-
imum of 20 metaphases were examined.
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Dinucleotide-Repeat Analysis
Primers for the microsatellite markers were either
obtained from Research Genetics or custom synthe-
sized. PCR was performed on 50 ng genomic DNA,
with the use of 0.2 mM each primer, 0.25 mM each
dNTP, 1.5–2.0 mM MgCl2, 1 # PCR buffer (PE Bio-
systems), and 0.25 U Taq DNA polymerase (PE Bio-
systems) for 35 cycles. PCR products were resolved
on an 8% denaturing polyacrylamide gel, were trans-
ferred onto Hybond N membrane (Amersham), and
were probed with a g[32P]-ATP–end-labeled, 70-base
CA-repeat oligonucleotide. Genomic DNA was pre-
pared as described elsewhere (Miller et al. 1988). PCR
products were run on 2.5% agarose gels and were
stained with ethidium bromide.
BACs/P1s
BACs were obtained from Research Genetics after
screening of the California Institute of Technology
(CIT)–arrayed human BAC library (Shizuya et al. 1992;
Kim et al. 1996), by means of PCR done on hierarchi-
cally pooled BACs. P1s were obtained from the library
of N. Sternberg (Shepherd et al. 1994). BAC DNA was
purified by use of a modified protocol from Qiagen. BAC
clones were grown overnight in 500 ml Luria-Bertani
broth supplemented with 10 mg thymine/ml and 12.5 mg
chloramphenicol/ml. The Maxi-prep protocol (Qiagen)
for single-copy plasmids was followed, with the follow-
ing changes: (1) volumes of buffers P1, P2, and P3 were
each 40 ml; (2) after isopropanol precipitation of DNA
from the supernatant obtained from the alkaline lysis
and after resuspension in 12 ml QBT buffer (Qiagen),
additional ribonuclease A was added to a final concen-
tration of 50 mg/ml prior to loading of the DNA onto
the Qiagen Tip-500 column; and (3) the final DNA pre-
cipitate was dissolved in 300 ml 10-mM Tris, pH 8.0,
and 0.1-mM EDTA. M13 universal forward and reverse
primers were used for end sequencing of the BACs. BAC
end sequences were analyzed by use of the BLAST al-
gorithm (Altshul et al. 1990) located on the Baylor Col-
lege of Medicine (BCM) Search Launcher site (Smith et
al. 1996). Repetitive sequences were identified by use of
RepeatMasker. BAC walking was done by designing new
primers from nonrepetitive BAC end sequences and by
screening the CIT-arrayed BAC library. P1 clones were
purified and were analyzed similarly.
cDNA Clones
I.M.A.G.E. Consortium (Lawrence Livermore Na-
tional Laboratory [LLNL]) cDNA clones correspond-
ing to ESTs in GenBank (Lennon et al. 1996) were
purchased from Genome Systems. These cDNA
clones—denoted by I.M.A.G.E. Consortium clone ac-
cession numbers 180467, 1018392, 178261, 198202,
221127, 41789, 31702, 221330, 113501, 82388, and
137340—corresponded to ESTs NIB327, SGC30425,
WI-15198, SGC34603, SGC31307, WI-13447, WI-
14334, SGC31297, SGC33503, SGC33325, and WI-
8719, respectively. The cDNA inserts from these
clones were digested with the appropriate restriction
enzymes and were used as probes for Southern and
northern blot hybridizations. Additional cDNA clones
were obtained by means of a PCR-based screen of a
human lymphoblast cDNA library (provided by M.
Buchwald; Strathdee et al. 1992) or were amplified
either by PCR from Marathon libraries (Clontech) or
by reverse transcriptase (RT)-PCR.
Southern Blot Hybridizations
Southern blot hybridization was performed by
means of standard procedures (Southern 1975). BACs
were digested with HindIII, were resolved on a 0.8%
agarose gel, and were transferred onto Hybond N1
membranes (Amersham). cDNA probes were labeled
with random hexamers and a[32P]-dCTP. Hybridiza-
tions were performed at 657C in 6 # SSPE, 0.5% SDS,
5 # Denhardt reagent, and 100 mg salmon sperm
DNA/ml. The membranes were washed for 15 min in
2 # SSC and 0.1% SDS at room temperature, then
for 15 min in 1 # SSC and 0.1% SDS at 657C, and
then for 5 min in 0.1 # SSC and 0.1% SDS at 657C
for higher stringency. Inter-Alu PCR products were
labeled in the same manner as were the cDNA probes;
they were then prehybridized with 500 mg human pla-
cental DNA. Blots were also prehybridized with hu-
man placental DNA.
Northern Hybridizations
Human adult and fetal multitissue mRNA blots were
purchased from Clontech. Blots were probed with cDNA
probes labeled as described above, were hybridized with
the use of the ExpressHyb hybridization solution (Clon-
tech) at 657C, and were washed at high stringency, also
as described above.
Inter-Alu PCR
Three separate PCR reactions were performed on 10
ng purified BAC DNA, by use of 3′ (5′-ACAGAGCGA-
GACTCCGTCTC-3′) and 5′ (5′-GTGAGCCACCGCG-
CCCGGCC-3′) Alu primers. One reaction included both
primers, and the other two reactions included each
primer by itself. Products from all three reactions were
pooled and were used as probes for Southern-blot-hy-
bridization analyses. PCR was done with 0.2 mM primer,
0.25 mM each dNTP, 2.0 mM MgCl2, 1 # PCR buffer,
and 0.5 U Taq DNA polymerase (PE Biosystems). The
PCR conditions were as follows: 30 cycles for 1 min,
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15 s at 947C; 3 min at 727C; and extension for 10 min
at 727C at the end of the PCR reaction. The PCR prod-
ucts were combined and were purified with the use of a
Qiaquick PCR purification column (Qiagen).
Results
Analysis of Microcell Hybrid Clone PD20-3-8
In the assignment of the FANCD region to chro-
mosome 3p22-26, a microcell hybrid cell line, PD20-
3-8, was generated (Whitney et al. 1995). This cell
line showed no increased resistance to MMC and
DEB, yet it maintained a neomycin-marked chromo-
some 3 from the GM11713 donor cell line. Marker
analysis of the hybrid was attempted, but there were
few informative markers in the chromosome 3p22-26
region. Therefore, the neomycin-marked chromosome
3 was isolated in a mouse background, by use of the
PD20-3-8 cell line as an MMCT donor and by use of
the HPRT2 immortalized mouse fibroblast cell line A9
as a recipient. After fusion of PD20-3-8 micronuclei
with A9 cells, the neomycin-marked chromosome 3
was selected with the use of G418, and carryover hu-
man cells were counterselected with the use of 6-thio-
guanine. Three independent PD20-3-8/A9 microcell
hybrids, C6–C8, were shown, by means of Southern
blot analysis, to carry the neomycin-marked human
chromosome 3. With only the single neomycin-
marked chromosome 3 present in the A9 mouse back-
ground, every mapped EST or sequence-tagged site
(STS) marker in the chromosome 3p22-26 region
could potentially be used to determine the extent of
the deletion. One marker that was absent in microcell
hybrids C6–C8 was D3S1597. An additional 15
markers—AFMA216ZG1, SGC33325, SGC31297,
SGC33503, SGC30425, SGC30473, SGC34603, WI-
14334, SGC31307, CHLC.GGAT2A11, NIB327,
D3S3691, NIB673, WI-6956, and WI-8719—12 of
which were ESTs, were also found to be deleted in
these clones. The breakpoints of the deletion in the
PD20-3-8 hybrid were delimited by markers D3S3591
and D3S3589. On the basis of the CEPH genetic map
of this region, this corresponded to a distance of ∼8
cM. Using the markers neighboring D3S1597 as a
framework, we then constructed a BAC/P1 contig.
Assembly of the Contig
The final BAC/P1 contig covering ∼1.2 Mb between
D3S3691 and the ATP2B2 gene is shown in figure 1.
The size of the contig was estimated from the size of
the genomic inserts on pulse-field gel electrophoresis
and an average overlap of ∼30 kb through the min-
imal tiling of BACs in the contig. This is consistent
with an estimated physical distance for the region
(Szymanski et al. 1993). The assembly was begun by
screening the CIT human BAC library (Kim et al.
1996) with the use of markers previously mapped be-
tween D3S3591 and D3S1293 (e.g., markers
SGC33325, SGC31297, SGC33503, SGC30425,
SGC30473, SGC34603, WI-14334, SGC31307,
CHLC.GGAT2A11, NIB327, D3S3691, NIB673, WI-
6956, and WI-8719) by the Whitehead Institute for
Biomedical Research/MIT Center for Genome Re-
search, the Stanford Human Genome Center, Ge´ne´-
thon, and the Cooperative Human Linkage Center.
This established a framework of BACs from which
multiple walks could be initiated; at that time, ∼20
STS and EST markers had been assigned to the chro-
mosome 3p25 region. BAC DNA was purified, and
the localization to chromosome 3p25 was verified, by
use of FISH, to metaphase spreads of normal human
cells. The ends of the human genomic inserts were
sequenced with the use of the M13 universal forward
and reverse sequencing primers flanking the p-
BeloBAC-11 vector multicloning site. Use of the
RepeatMasker algorithm available from the BCM
Search Launcher identified repeat-free sequences from
which the PCR primer pairs were designed. Usable
sequence was obtained ∼70% of the time. These PCR
primers were then used to search the arrayed BAC
library for overlapping BACs. In addition, the new
primers were tested against the initial set of frame-
work BACs, with the objective of linking small clus-
ters of BACs together. As the size of these clusters
increased, testing of newly designed primers on the
assembly linked more clusters together. A list of PCR
primers developed from the BAC end sequence is given
intable 1.
Southern blot analysis and FISH were used to verify
the location of BACs within the contig. For Southern
blot analyses, BACs were digested with HindIII and were
probed with cDNAs obtained either from the I.M.A.G.E.
Consortium (LLNL; Lennon et al. 1996) or from RT-
PCR. Inter-Alu PCR products of BAC DNA were also
used as probes. For this type of Southern blot test, probes
and membranes were prehybridized with human pla-
cental DNA to block repetitive DNA sequences. For in-
terphase FISH, entire BACs were used as probes in a
pairwise ordering, with respect to the p-terminus of
chromosome 3. One BAC probe was detected with the
use of an FITC (green) secondary label, whereas the
second BAC probe was detected with the use of a rho-
damine (red) secondary label. Two chromosomal
spreads, one with the p-terminus labeled with FITC and
the other with the p-terminus labeled with rhodamine,
were then compared. For example, if the linear order on
one spread was green-green-red and that on the second
spread was red-green-red, then the BAC labeled with
FITC would be closer to the p-terminus than would the
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Figure 1 BAC contig in chromosome 3p25-26. A total of 38 BACs and three P1 clones covering ∼1.2 Mb in chromosome 3p25-26 are
represented. Marker D3S3591 is telomeric to the contig. BACs corresponding to this marker were identified but did not overlap the contig.
The distance between D3S3591 and D3S3691 is estimated to be 4.2 cR (GeneMap’99). Markers D3S3589 and D3S1293 are centromeric to
the contig, with D3S1293 located ∼12.8 cM from D3S1597 (GeneMap’99). Underlined BACs were confirmed by FISH, with use of the two-
color strategy presented in figure 2. Markers confirmed by Southern blot tests are denoted by the number symbol (#). The small open rectangle
on BAC210B10 denotes the absence of marker D3S1597 on this BAC, possibly as a result of a small deletion or polymorphism. Ends of BACs
tagged with open circles represent sequences from which new PCR primers were derived, and dashed lines indicate the correspondence of these
PCR primers on overlapping BACs. Markers grouped together, such as TIGR-A004P23 and WI-17366, are not yet ordered with respect to one
another. Deletions on the donor chromosome of noncomplemented microcell hybrids are shown beside the contig, with the common overlapping
deleted region appearing in a box.
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Table 1
List of New STS Markers Derived from the BAC End Sequence
Primer BAC Primer Sequence
Product
Size
(bp)
MG316 300K6 GACATTCTTCCAACCACTTTCC 303
MG317 300K6 GGTGGATCAGGCTAGAAAAGG
234F-1 234M14 CAGACATCACCCCATCACTG 165
234F-2 234M14 GAGCCTTCATCTTTGGGTAGG
187R-1 187A24 CAAGTGAATCTTGAGCAACTGC 124
187R-2 187A24 TCTGTTCACTGACCACAGCTG
187F-1 187A24 TCCAGTGAACAAACATAGCACC 114
187F-2 187A24 TTTTAGCACTGGTGGGCAG
183R-1 183K15 AACCTTTATGGGAACCAATGC 139
183R-2 183L15 TTACAAAAGTGTGGGAGCCC
293C22F-1 293C22 TTACCTTCTGCCAAAATGGC 153
293C22F-2 293C22 TGCTCCTTGACTTATGATGGG
20A10R-1 20A10 ACTTAGGCAGTGTTTCCCTCC 218
20A10R-2 20A10 CCAAAAGTGTGAGGGAGGAC
234R-3 234M14 GAGGAAATGCATCCTTCTGC 101
234R-4 234M14 GCTGAAGGGGTTAGTTCGC
123F-1 123H15 TGCAAAATGAGGACAACAAG 177
123F-2 123H15 CTCAAGGCTCCGTCAAACTC
343R-1 343N13 CCTACTCCCAACCCTGGAG 153
343R-2 343N13 TTGAGTCCCATCCTCCAAAC
102R-1 102F6 GCACATTAAAACTCACTCCTGC 183
102R-2 102F6 GAGATGGGGCACCAGAAAC
168JF-1 168J6 ACTGTGCTCTCCCTCCCC 178
168JF-2 168J6 GAAGAATTTGTTAGTGGCCTGG
334F-1 334F6 CCTCTGGTAGTCTGCTTGGC 147
334F-2 334F6 AGATGTGGTCAGGCTCGG
334R-1 334F6 TTTGTGCATTTGAGTATTTGGC 392
334R-2 334F6 AAGTGGGATGCAGACTGACC
269R-1 269B10 GTCACTTTGCATTCCCTACTCC 174
269R-2 269B10 GGTAAGGCAGAAAGGAGCG
269F-1 269B10 CCATATTTTTTGTGTTCACAAGG 165
269F-2 269B10 AGAACCCCTCTTACAAGTTCCC
177F-1 177N7 CAGGGTCATGATATTCAACTCC 104
177F-2 177N7 CAAGACTTTTCCAGGCAGTG
177R-1 177N7 TCATTTCAGACAAATCCATTGC 196
177R-2 177N7 GCTGGGATTATAGGCGTGAC
159F-1 159N23 GAGCCGAAAGTAAGGGCTG 261
159F-2 159N23 TTGAGGAAGGAGAGCTAAGTGG
93-R1 93A5 ACCATTGGATTGCACCTACCAC 220
93-R2 93A5 TGAGATGGATTTCCCAGCAGTC
P39T-1 P1 39F12 TTCATATTCTTCCCCCTCCC 136
P39T-2 P1 39F12 CTAACCACAAAAACCTTCCAGG
P91S-1 P1 91E6 GCATATGCTTCAGAATCCCTG 127
P91S-2 P1 91E6 AAAGTCCCATGGCTGTGAAG
P56T-1 P1 56F11 TGCACAGGAATGCTTAGCAC 259
P56T-2 P1 56F11 GTTGAATAGTCTTCCTCCCACG
P56S-1 P1 56F11 CTGAAGAAGATTGAAACCCACC 150
P56S-2 P1 56F11 CATGAGCCGTGATTGAACC
61D11R-1 61D11 GGTCACAGAAAGTTCTAAGTGG 95
61D11R-2 61D11 GCCCTACGTCCTTTATGG
61D11T-1 61D11 TGTTCCAGATGAATCCAAAGCC 130
61D11T-2 61D11 GGTAGCAGGAGGTTAAATGCACC
Table 1 Continued
Primer BAC Primer Sequence
Product
Size
(bp)
183F-3 183L15 CACTTTACACTTTCCTGGACTCCAC 130
183F-4 183L15 TTGGGTCTGCCACTTAAAAGAGAG
183NS3 183L15 CGGGTGTTCAAAAAATACCAGG 95
183NS4 183L15 ACAGGTGAGAAGTTTCTCCCCC
39T-3 P1 39F12 TGAAACAGAGCAATGCCTGTCC 300
39T-4 P1 39F12 TGCAAGGCACTGAGGAGATGAG
393F-1 393J18 ACGGGCAACAGATAGAAATTC 118
393F-2 393J18 TGACACATAGATAAAAGTGCTTGAG
393R-1 393J18 GCCTCTAAGTGTTCAAGTGAAAGG 105
393R-2 393J18 GTGCTGGGATAACAAGCGTG
558F-1 558E6 TTATCACCCCACTTTATAGAGCAG 142
558F-2 558E6 TTTCACCAGGCGGATAGTTC
187PF-1 187P1 CCCAGGTTATGGAACTCAGC 92
187PF-2 187P1 TATGTGCTGCTCCATCCTTG
187PR-1 187P1 CAACTTGTGTCTCAGTGCAGTTC 112
187PR-2 187P1 GATTTCCAATACAGGCAGTGG
109F-1 109F16 CATGGCAGTCATTACTCTGTTTC 108
109F-2 109F16 ATCTGAAGGGGATGTTGAGG
109R-1 109F16 CCATATTGGGCACTGACTTATC 146
109R-2 109F16 GACTAAAGCAGTTTTCAGGGC
168DF-1 168D4 CTCCACTGGATGTAACAATGTTC 113
168DF-2 168D4 CCTTCCCATCACTTTGGTGG
168DR-1 168D4 CCAACCCACATCTCACAGGAG 151
168DR-2 168D4 CCCTTATCCTGCCCTCAATG
100F-1 100I3 TTCTGGAAGTCAGGCTGGC 99
100F-2 100I3 TCATTTATTTCCAGCCCCC
100R-1 100I3 CCAAGGCTATCCAGTGAACAAAC 181
100R-2 100I3 AAAGAATCGGGGAAGAAGGAAG
140F-1 140G19 TCAGTGATCTCTGTCAGGGAGG 140
140F-2 140G19 CGAGGCTGAGGAATTGTTTTAC
172F-1 172I17 CCACAGCTTCATCAAGGGTG 110
172F-2 172I17 TGCAGTTATGGATGGAGGATG
448F-1 448N22 ACAGGCTAGATTTGCATGTTTC 100
448F-2 448N22 CGGTATAAAGGGAGAATGGC
448R-1 448N22 GACAACACTGAAAAGGGAACG 120
448R-2 448N22 CCACCATTTTGCATACGATG
134F-1 134A23 AGACCTCAGGACATCAGAGGC 105
134F-2 134A23 GCATGAGCAGATGGAGTATGG
134R-1 134A23 GTTGACCCCAAGGTGAAATG 104
134R-2 134A23 GACAATGCTAACGCCTTTGC
320F-1 320K16 GGTCTTTTTCAACTCTGTGGC 156
320F-2 320K16 AGCAATTTCAGCAGGTCAGC
558R-1 558E6 CCCAAGTTCCATGAAGTGTATG 441
558R-2 558E6 TGATGAGTACACAGGGTTCAGAG
551R-1 551O20 GCAAAGGAGTTTTCTGGGAGGC 118
551R-2 551O20 AAGTGTCAAGCAGGGCTTCTGGAC
551F-1 551O20 GTATGTCCATGATGAAAGCTGCTG 116
551F-2 551O20 AAATATGCCCCTGAGGTTTTCC
152R-1 152B1 GTTGCATACAGCAAGAGGATAGAGC 246
152R-2 152B1 CAACAAAGGACTGGTCAGGAAGC
152F-1 152B1 CCTTTCTCCTCTCCACCCTTAAAC 187
152F-2 152B1 CTTTTTCCAGCCTCCTGAAGAAC
1546 Am. J. Hum. Genet. 66:1540–1551, 2000
Figure 2 Interphase FISH mapping of two BACs (A and B) from the contig on a normal human interphase and deletion mapping on
noncomplemented microcell hybrids (C and D). To determine the order of the BACs, two analyses were performed with each BAC pair. The
BACs were labeled in the same color, respectively, in both analyses, with the chromosome 3p subtelomere labeled in green in the first analysis
and labeled in red in the second analysis. Panel A shows green (3p subtelomere [arrow])–green (BAC 551O20)–red (BAC168D4). This order
is confirmed by the results of the second analysis (B), which show red (3p subtelomere [arrows])–green (BAC 551O20)–red (BAC 168D4). C
and D, Noncomplemented microcell hybrid cells were probed with BACs from the contig, and the presence or absence of a signal on the donor
chromosome 3 was determined. The donor chromosome in this example was identified by a chromosome 3–specific a-satellite probe (red) that
was split on the donor chromosome (short arrow). Panel C shows PD20-3-71 cells probed with BAC 551O20 (green) and the a-satellite probe.
In this example, the BAC hybridized to the donor chromosome (long arrow). Panel D shows PD20-3-71 cells probed with BAC 134A23 (green)
and the a-satellite probe. In this example, the BAC failed to hybridize to the donor chromosome (long arrow), although it hybridized to the
PD20 resident chromosomes. The deletion on the donor chromosome thus included BAC 134A23.
BAC labeled with rhodamine. This allowed for the pair-
wise ordering of BACs at a resolution of 50–100 kb
(Trask et al. 1991). An example is presented in figure
2A and B.
On one occasion, gaps were filled with P1 clones. An-
other gap between BACs 393J18 and 134A23 (fig. 1)
was filled by BAC 2377N12. The end sequence of
2377N12 (GenBank accession number AQ112748; In-
stitute for Genome Research BAC End Sequencing Pro-
ject) shared homology with the 5′ end sequence of
I.M.A.G.E. Consortium cDNA clone 43420 (GenBank
accession number H12922) in the UniGene human-se-
quence cluster Hs. 157071 (the 3′ end of the same clone
has been placed in cluster Hs. 27556, along with EST
stSG2582). FISH analysis indicates that BAC 2377N12
maps to chromosome 3p25-26 and that it contains the
PCR markers derived from both of the BACs flanking
the gap. Coverage in the middle of the contig is rather
poor and may reflect either an unstable region or se-
quences that are difficult to clone. The entire contig has
been submitted to the Baylor College of Medicine Hu-
man Genome Sequencing Center, as a contribution to
the human-genome-sequencing effort.
Locating cDNAs on the Contig
During the construction of the contig, new ESTs were
continually binned to the chromosome 3p25 region by
the human genome centers (Deloukas et al. 1998), and
these ESTs were mapped directly, by use of PCR, to
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Table 2
Northern Blot Analysis of Mapped ESTs
EST
Size
(kb) Expression Pattern
NIB673 7.5 and 9.5 Highly expressed in
brain; low expression
in heart, placenta,
lung, skeletal muscle,
and pancreas
SGC31307 3.0 Ubiquitous expression,
with the highest lev-
els in the liver, heart,
skeletal muscle, and
pancreas; low expres-
sion in brain
SGC30425 6.0 Highly expressed in
liver
SGC34603 5.0 Ubiquitous, low-level
expression, with
highest expression in
placenta and lowest
expression in skeletal
muscle
WI-6956 4.4 Highly expressed in
brain; lower expres-
sion in kidney and
pancreas
SGC33503 1.0,a 1.4, 2.6,a
and 3.0
Ubiquitous expression,
with highest levels in
heart and skeletal
muscle
EST-AA609512 1.1 Testis specific
a These transcripts appear to be present only in heart and
skeletal muscles.
specific BACs in the contig. Under the assumption that
there is one gene per EST, the total number of genes in
this region is at least 36, with a gene density of ap-
proximately one gene per 40 kb. BLAST homology
searches with BAC end sequences revealed the presence
of the von Hippel-Lindau tumor-suppressor gene (VHL)
near the centromeric end of the contig. A 400-kb cosmid
contig covering VHL and ATP2B2 has been reported
(Kuzmin et al. 1994); it partially overlaps the BAC contig
described here. The order of markers in this overlapping
region is in agreement with that of Kuzmin et al. (1994)
Additional ESTs that were identified, on the basis of
BLAST homology searches, from end sequences of BACs
were T07632, AA609512, F21841, and AA715826
(GenBank accession numbers), located on BAC 343N13,
BAC 152B1, BAC 123H15, and BAC 293C22, respec-
tively. On the basis of both the results of multitissue
northern blot tests and the fact that the only library from
which the cDNA could be amplified was derived from
testis, the EST AA609512 appears to be testis specific.
To assess the pattern of expression of several of the
cDNAs in the region, tissue-specific northern blot tests
were hybridized with cDNA probes. A summary of these
results is given in table 2. Two genes—NIB673 and WI-
6956—appear to be highly expressed in the brain. These
are of potential interest with regard to two rare syn-
dromes, 3p2 syndrome and duplication 3p syndrome
(or trisomy 3p syndrome; Martin and Steinberg 1983;
Phipps et al. 1994; Drumheller et al. 1996), which both
involve mental retardation as one of several clinical
manifestations.
Other well-characterized genes that have been placed
on the contig are the oxytocin receptor (OXTR) on
BACs 234M14, 61F4, and 243A6; calmodulin kinase-
1 (Haribabu et al. 1995), which was shown to partially
overlap the 3′ end of hOGG1 (Aburatani et al. 1997);
and ATP2B2 (Brandt et al. 1992), which was mapped
to the YAC/cosmid contig containing VHL (Kuzmin et
al. 1994). Interestingly, ATP2B2 has recently been as-
sociated with mutations that cause deafness and imbal-
ance (Kozel et al. 1998; Street et al. 1998). End sequence
from BAC 152B1 identified the gene IRAK-2 by means
of BLAST search homology.
Testing hOGG1 and IRAK-2 for Functional
Complementation
The human homologue of the yeast gene ogg was con-
sidered to be a candidate for FANCD. Primary FA cell
lines have been reported to be oxygen sensitive (Saito et
al. 1993), and the human gene encodes an 8-hydroxy-
guanine glycosylase, an enzyme responsible for the re-
pair of one of the prevalent lesions produced by reactive
oxygen species (Aburatani et al. 1997; Lu et al. 1997;
Radicella et al. 1997; Roldan-Arjona et al. 1997). The
full-length normal hOGG1 cDNA was obtained, by
means of RT-PCR, from control cell line PD138. Two
different normal splice variants, one of which is 17 bp
longer than the other, were separately subcloned into the
pREP4 expression vector. In addition, the analogous two
cDNA splice variants were amplified from PD20-im-
mortalized FANCD fibroblasts and were subcloned into
pREP4. PD20 FANCD cells were electroporated with
each of the expression constructs, respectively, and, after
selection with hygromycin B, individual clones were cy-
togenetically tested for genomic stability after treatment
with MMC and DEB. None of the transformed PD20
fibroblasts showed improved genomic stability after
treatment with these agents. Expression of the normal
hOGG1 cDNA from the Rous-sarcoma-virus promoter
of the pREP4 vector was verified by use of the northern
blot test. In addition, RT-PCR products from normal
cells and PD20 cells were sequenced, and no sequence
alterations were detected. On the basis of these results,
the hOGG1 gene was excluded as a candidate for the
FANCD gene.
IRAK-2 (Muzio et al. 1997) was tested because FA
cells have been shown to be hypersensitive to interferon-
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g (Whitney et al. 1996). Conceivably, an interleukin-1
receptor–associated kinase might also interact with sev-
eral different signal transduction pathways. A full-length
cDNA clone was obtained by screening of the Strathdee
library and was tested for functional complementation
of PD20 cells. There was no indication that IRAK-2
cDNA corrected the genomic instability in PD20 cells
after treatment with MMC and DEB. Mutation detec-
tion was not attempted. As described below, narrowing
of the FANCD critical region ultimately excluded both
hOGG-1 and IRAK-2 as candidate genes.
Production and Analysis of Additional
Noncomplemented Hybrids
To refine the FANCD critical region, additional mi-
crocell hybrids were generated by use of the GM11713
donor and PD20 recipient cells, as previously described.
Two hundred fifty independent neomycin-resistant hy-
brid cell lines were tested for complementation with the
chromosomal-breakage assay. Of the 250 clones, 7 re-
tained high levels of chromosomal breakage after treat-
ment with MMC and DEB. The seven noncomplemented
clones were analyzed for deletions by use of the infor-
mative markers D3S3591, D3S1597, D3S1317, and
D3S1263. Three of these clones lacked all four markers.
This indicated that the donor chromosome had a dele-
tion larger than the current region of interest; conse-
quently, these three clones were not studied further. The
four remaining noncomplemented clones—PD20-3-63,
PD20-3-71, PD20-3-308, and PD20-3-329—retained
the D3S1597 marker in common but lacked at least one
of the other informative markers, suggesting the presence
of deletions that were partially overlapping or that were
smaller than the original PD20-3-8 deletion.
The BAC/P1 contig was exploited in mapping of the
deletions in the four new noncomplemented hybrid
clones. A FISH probe was developed to identify the ne-
omycin marker on the donor chromosome 3, and BAC
FISH probes were then used to determine the presence
or absence of the corresponding region on the donor
chromosome. The recipient chromosome 3 signals
served as internal controls, and no large deletions were
ever observed on the recipient (FANCD) chromosomes
in the chromosome 3p25-26 region, implying that the
genetic defect in the PD20 cell line is not a large deletion.
Figure 1 summarizes the contig and the breakpoints of
the deletions in the noncomplemented hybrid cell lines.
Each of the 41 BACs or P1s depicted in figure 1 was
independently used as a FISH probe in mapping of the
deletions. Hybrids PD20-3-71, PD20-3-308, and PD20-
3-329 all had deletions extending beyond the proximal
end of the contig. The distal breakpoint in both PD20-
3-71 and PD20-3-308 lay within the region represented
by BAC 187G23. In this region of the contig, the depth
of coverage in the CIT BAC library was less than the
sixfold average, suggesting that this might be a hot spot
for chromosomal breaks. The distal breakpoint for the
deletion in PD20-3-329 was within BAC 343N13.
PD20-3-63 carried two deletions on the donor chro-
mosome. One deletion began within BAC 334F4 and
extended beyond the distal end of the contig, whereas
a second, very small deletion was detected only by the
absence of a hybridization signal from BACs 135J2 and
177N7. The deletions in the donor chromosomes from
all five noncomplemented hybrid cell lines overlapped
in this one small region. The size of the insert in BAC
177N7 was determined to be 100 kb, by means of pulse-
field gel electrophoresis. Assuming that the deletion in
PD20-3-63 could extend somewhat beyond the region
delimited by BAC177N7 and that it could disrupt the
function of the genes flanking the deletion, we estimated
that the FANCD gene must lie within a region of ∼200
kb, centered around the EST SGC34603. The ESTs
SGC34603, TIGR-A004X28, and AA609512 are cur-
rently being evaluated as candidates for the FANCD
gene.
Discussion
Mapping of FANCD
The International Radiation Hybrid Mapping Con-
sortium, with its wealth of STS and EST markers in
easily searchable databases, in conjunction with the de-
velopment of arrayed BAC libraries, allows for the as-
sembly of BAC contigs covering several megabases of
sequence. These contigs will accelerate the development
of human sequence data as well as the fine mapping of
critical regions in the search for genes implicated in ge-
netic diseases. In the case of FANCD, BACs from the
chromosome 3p25-26 contig were used as FISH probes,
to map the deletions in the donor chromosome in five
noncomplemented microcell hybrid cell lines. Although
it is possible that a noncomplemented clone could arise
from the spontaneous deletion of another FA gene in the
recipient cell, this event would be extremely unlikely,
since all known FA mutations are recessive—that is, such
an event would have to entail the loss of both alleles.
The FANCD critical region is contained within ∼200 kb
centered around the EST SGC34603. The corresponding
cDNA as well as cDNAs corresponding to the ESTs
TIGR-A004X28 and AA609512 are thus the leading
candidates for the FANCD gene.
BACs have been demonstrated to directly complement
mutant cell lines (Hejna et al. 1998), and several ex-
periments have been performed with BACs from the
chromosome 3p25 contig, to test for functional com-
plementation after electroporation of BACs into PD20
fibroblasts. Direct functional complementation of PD20
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cells with BACs has thus far been unsuccessful. The BAC
vector has no selectable marker; consequently, comple-
mentation was tested by means of direct selection with
DEB after electroporation. In control experiments, PD20
fibroblasts showed an appreciable background of DEB-
resistant colonies under continuous DEB selection, pre-
sumably as a result of reversion of the FANCD gene.
This background could be eliminated by retrofitting the
BACs with a selectable marker, such as hygromycin re-
sistance. Now that the FANCD region of interest is cov-
ered by only three or four BACs, such a project is
feasible.
An advantage of using BACs for contig building is
that they are only rarely chimeric. In the present study,
we found only one BAC that appeared to be chimeric.
It was noted, in the earlier YAC/cosmid contig covering
the VHL region, that many of the YACs were chimeric
toward the telomeric end of the contig (Kuzmin et al.
1994). One basis for this observation might be that there
is an inherently unstable site in that vicinity. We have
observed amplification of this entire region in PD20 fi-
broblasts, under DEB selection (D. A. Bruun, unpub-
lished data); the breakage-fusion-bridge model of am-
plification would predict a fragile site in the vicinity
(Coquelle et al. 1998). In addition, the representation
of BACs in the CIT BAC library decreased from ap-
proximately sixfold in the region adjacent to VHL to
onefold through the middle of the contig, suggesting that
the DNA in this region is difficult to clone or to maintain
in other vectors as well. In addition to deletion break-
points associated with von Hippel-Lindau disease or tu-
mors, the region has been associated with translocation
breakpoints and fragile sites (Porfirio et al. 1991; Sbrana
and Musio 1995; Schmidt et al. 1998).
The region has recently been associated with loss of
heterozygosity in ovarian cancer (Fullwood et al. 1999).
BAC FISH probes from the contig may narrow the re-
gion of interest for a putative tumor-suppressor gene in
the vicinity. The cDNA Br140, which maps to BACs
134A23, 100I3, and 168D4, has been completely se-
quenced (Thompson et al. 1994) and belongs to a family
of zinc-finger, leucine-zipper motif genes that have been
disrupted in translocations associated with acute mye-
loid leukemia (Gregorini et al. 1996). The above-men-
tioned BACs would serve as excellent probes with which
to test whether a similar translocation breakpoint might
disrupt the Br140 gene in related leukemias.
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